Kolin C. Hribar PhD

Kolin C. Hribar, PhD, is founder and CEO of Cypre Inc. Since its inception in 2016, Kolin has led a multi-disciplinary team in the development of their bioprinting platform and subsequent oncology collaborations with pharma and academia. The guiding mission at Cypre is to build a new set of 3D cell culture tools that enable scientists and clinical researchers in their pursuit of higher impact, complex phenotypic screening and patient-specific testing. Kolin received his PhD in Nanoengineering from UC San Diego and his Bachelors and Masters in Bioengineering from the University of Pennsylvania. He has published in peer-reviewed journals such as Nature Materials, Advanced Materials, ACS Nano, to name a few.